Lv1
72 积分 2024-12-18 加入
Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation
2天前
已完结
Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
1个月前
已完结
Defining the Complement Biomarker Profile of C3 Glomerulopathy
1个月前
已完结
Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies
1个月前
已完结
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin–Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial
1个月前
已完结
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
1个月前
已完结
Complement in human disease: approved and up-and-coming therapeutics
1个月前
已完结
Comparison of outcomes after plasma therapy or eculizumab in pediatric patients with atypical hemolytic uremic syndrome
1个月前
已完结
The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab
1个月前
已完结
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan
2个月前
已完结
皖公网安备34019202002308
